Article Citations

(Scroll Down for More)

A Phase 2a trial of Teplizumab and RN168 in patients with new onset type 1 diabetes mellitus

Principal Investigator

Kevan Herold | Yale School of Medicine | New Haven, CT

Locations

Study Code

ITN083AI

Study Status

Withdrawn

Abstract

Qualification

Articles